InvestToChina >> News >> Life Sciences

Life Sciences

China blacklists 23 websites selling fake drugs

China's drug safety watchdog has blacklisted 23 websites, which were found to have been selling fake drugs or to have published illegal adverts.

LIVZON Pharmaceutical Group Inc, a Chinese drug maker, announced plans to buy back Hong Kong dollar-denominated shares.

AMAG Pharmaceuticals has tied up with China's 3Sbio to develop and commercialize ferumoxytol

Latest: 09/07/02TCM modernization speeds up; 09/04/22Sanofi-aventis invests to expand Beijing plant; 09/04/06Health care reforms are a shot in the arm; 09/03/20Deal on 3 JVs; 09/03/10Sinovac's Subsidiary Obtains High-Tech Enterprise Status; 09/03/03Value seen to rise; 09/03/03SFDA Commissioner Shao Mingli meets the Director of Federal Service on Surveillance in Healthcare and Social development of Russian Federation; 09/03/02SFDA issues the No.135 announcement of drug administrative protection; 09/03/02Shijiazhuang Pharma's Vitamin B12 passed EU inspection; 09/03/02Center for Drug Evaluation of SFDA issues Working Procedure for Drug Registration Second Review (interim); 09/02/27CSPC Sales Revenue hit over 10 Billion yuan in 2008; 09/02/18Prices of some big-size APIs increased; 09/02/13China suspends use of an herbal injection after death reported; 09/02/13SFDA issues Guidelines on the Protection of Traditional Chinese Medicines; 09/02/12Bayer invests $129mn on Beijing R&D center

Biotechnology: 09/02/09TVG launches BioPartnering China; 08/12/05WuXi PharmaTech ends manufacturing operation in US; 08/12/03New use for plant; 08/05/30Simcere gets SFDA approval of biapenem injection Anxin; 08/04/14Cancer drugs boost profit at Genentech; 08/04/14Biotech sector shows bright future; 08/04/03China authorizes commercial production of human bird flu vaccine; 08/04/03Transgenomic opens pharmacogenomics lab in China; 08/03/26Lucid receives SFDA approval to market VivaScope Microscope in China; 08/03/25Alnylam grants Shanghai GenePharma license for RNAi research products; more...

Pharmaceutical: 09/07/02TCM modernization speeds up; 09/04/22Sanofi-aventis invests to expand Beijing plant; 09/03/20Deal on 3 JVs; 09/03/10Sinovac's Subsidiary Obtains High-Tech Enterprise Status; 09/03/03Value seen to rise; 09/03/03SFDA Commissioner Shao Mingli meets the Director of Federal Service on Surveillance in Healthcare and Social development of Russian Federation; 09/03/02SFDA issues the No.135 announcement of drug administrative protection; 09/03/02Shijiazhuang Pharma's Vitamin B12 passed EU inspection; 09/02/27CSPC Sales Revenue hit over 10 Billion yuan in 2008; 09/02/18Prices of some big-size APIs increased; more...

Medical: 09/04/06Health care reforms are a shot in the arm; 09/03/02Center for Drug Evaluation of SFDA issues Working Procedure for Drug Registration Second Review (interim); 09/02/13SFDA issues Guidelines on the Protection of Traditional Chinese Medicines; 09/01/10Neo Derm Group New look for center; 09/01/09Govt to boost medical services; 09/01/08China moves to prevent bird flu outbreak after teenager dies; 09/01/07China issues bird flu alert after woman dies; 09/01/07China Medical Technologies sells HIFU business for US$53.5 mln; 09/01/05Requirements for Medical Device Adverse Event Monitoring and Re-evaluation (interim) issued; 08/12/17The Ministry of Agriculture and SFDA jointly issue an urgent notice on intensifying the supervision of ephedrine; more...